Penserra Capital Management LLC Tekla Life Sciences Investors Transaction History
Penserra Capital Management LLC
- $4.61 Billion
- Q3 2024
A detailed history of Penserra Capital Management LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Penserra Capital Management LLC holds 776,002 shares of HQL stock, worth $10.5 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
776,002Holding current value
$10.5 Million% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
77Shares Held
9.31MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$46.3 Million1.1% of portfolio
-
Morgan Stanley New York, NY490KShares$6.61 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY469KShares$6.33 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.63 Million0.14% of portfolio
-
Needham Investment Management LLC New York, NY353KShares$4.76 Million0.43% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...